Xodus Medical Gains FDA Clearance for Hot Pink Pad

PITTSBURGH, Pa., April 17, 2026

Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k) clearance, introducing an integrated solution for surgical patient temperature management and positioning. The device combines active warming technology with secure patient positioning, addressing two of the most critical perioperative risks—inadvertent perioperative hypothermia (IPH) and hospital-acquired pressure injuries (HAPIs)—while improving operating room efficiency and patient safety outcomes.

Integrated Technology Targets Key Surgical Risks

The Hot Pink Pad® represents a significant advancement in perioperative care, delivering precise, evenly distributed warming using carbon-based conductive technology directly beneath the patient. Unlike traditional forced-air systems, this approach maintains normothermia without disrupting the sterile field, ensuring safer and more controlled surgical environments.

Inadvertent perioperative hypothermia affects more than 40% of surgical patients and is associated with increased risks of surgical site infections, blood loss, impaired drug metabolism, and prolonged recovery times. By integrating intelligent normothermia software, the system continuously monitors and adjusts temperature levels, enabling consistent thermal regulation without increasing clinical workload.

Additionally, the device incorporates clinically proven positioning technology, preventing patient movement even during steep Trendelenburg procedures, and significantly reducing the risk of pressure-related injuries. Its single-use design eliminates cross-contamination risks, further enhancing patient safety and infection control.

Clinical and Operational Benefits Drive Adoption

The Hot Pink Pad® is designed to improve both clinical outcomes and operational efficiency in modern surgical settings. Clinical studies referenced in the release demonstrate significant reductions in pressure injuries and postoperative complications, reinforcing its role in improving perioperative quality metrics.

The system supports a wide range of procedures, including robotic, laparoscopic, and cardiovascular surgeries, thanks to its flexible, radiolucent design. It also features rapid one-person setup, silent operation, and intuitive controls, reducing setup time and enhancing workflow efficiency in busy operating rooms.

From an economic perspective, the device helps hospitals reduce costs associated with complications. Pressure injuries alone can add more than $40,000 per patient stay, making prevention strategies critical for both patient outcomes and healthcare system sustainability.

Advancing Surgical Innovation and Sustainability

Manufactured in the United States, the Hot Pink Pad® reflects Xodus Medical’s commitment to innovation, sustainability, and patient safety. The product incorporates biodegradable materials and energy-efficient design, aligning with growing industry focus on environmentally responsible healthcare solutions.

The device also aligns with guidelines from organizations such as the Association of periOperative Registered Nurses (AORN), supporting best practices for continuous temperature management and patient positioning throughout the perioperative cycle.

By addressing both clinical challenges and operational inefficiencies, the Hot Pink Pad® positions itself as a next-generation surgical solution, helping healthcare providers deliver safer, more efficient, and higher-quality care.

The launch of the Hot Pink Pad® following FDA clearance underscores the growing importance of integrated medical device solutions in surgical care. By combining advanced warming technology with secure positioning, Xodus Medical is addressing critical gaps in perioperative safety while improving clinical outcomes, operational efficiency, and healthcare sustainability.

Source: Xodus Medical press release